Vascular access route venture of the chronic hemodialysis patient: A prospective cohort study

医学 血液透析 动静脉瘘 高血容量 肾病科 中心静脉导管 内科学 前瞻性队列研究 导管 肾脏疾病 重症监护医学 外科 急诊医学 血容量
作者
Dilek Gibyeli Genek,Alper Alp,Okşan Uyar Gazezoğlu,Bülent Huddam
出处
期刊:Vascular [SAGE Publishing]
卷期号:33 (2): 325-334
标识
DOI:10.1177/17085381241244867
摘要

Objectives This study aimed to collect evidence to improve the arteriovenous fistula practice by investigating vascular access routes and by identifying the factors influencing the preferred types of vascular access routes for the first-time hemodialysis in our center. Methods We performed an epidemiological, prospective, cohort study. The study included 308 patients, who underwent hemodialysis for the first time between March 2023 and August 2023 in our hemodialysis center. We evaluated biochemical parameters, preferred vascular access routes for the first-time hemodialysis, planned/emergency hemodialysis status, the qualifications of the healthcare provider, who inserted the central venous catheter, if applicable, the presence of hypervolemia, anticoagulant use, nephrology follow-up findings, and in-hospital mortality in all patients and in those, who continued with chronic hemodialysis. Results The number of patients, who continued with chronic hemodialysis, was 167 (54.2%) and a temporary internal jugular central venous catheter was the most commonly preferred vascular access route for the first-time hemodialysis (47.3%). A central venous catheter was most commonly inserted by a nephrologist (53.7%) in chronic hemodialysis patients. Of the patients continuing with chronic hemodialysis, 45.5% were followed up in the nephrology outpatient clinic, 9.6% initiated hemodialysis on a planned basis, and 8.4% initiated hemodialysis with an arteriovenous fistula. A temporary internal jugular central venous catheter was commonly preferred when patients were followed up in the nephrology clinic and when the insertion was performed by a nephrologist; a transient femoral central venous catheter was commonly preferred in case of hypervolemia ( p < .001, p < .001, and p = .028, respectively). Age, gender, etiology, anticoagulant use, or biochemical test results did not act on the selection of the access site for the insertion of central venous catheter at the time of the first hemodialysis treatment. The access site for central venous catheter was not associated with in-hospital mortality ( p = .644). In the overall patient group, the in-hospital mortality was significantly low in patients followed up in the nephrology clinic ( p = .014). Conclusion The use of pre-emptive arteriovenous fistula for the first hemodialysis treatment occurs much less commonly than expected. Hemodialysis initiation rates with pre-emptive arteriovenous fistula lag behind nephrology outpatient follow-up rates.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hhhhh发布了新的文献求助10
刚刚
科研通AI6.2的应助被雅风采纳,获得10
刚刚
领导范儿的应助被lzq采纳,获得10
1秒前
檀兮尔发布了新的文献求助10
1秒前
深情安青的应助被许右采纳,获得10
2秒前
2秒前
2秒前
余又发布了新的文献求助10
2秒前
2秒前
shery完成签到,获得积分10
3秒前
3秒前
王jyk发布了新的文献求助10
3秒前
搜集达人的应助被sun采纳,获得10
4秒前
阿啊啊完成签到,获得积分10
5秒前
5秒前
酷波er的应助被千里洛采纳,获得10
5秒前
6秒前
落羽发布了新的文献求助10
6秒前
6秒前
cc完成签到,获得积分0
7秒前
募雨qaq发布了新的文献求助10
7秒前
啦啦啦完成签到,获得积分20
7秒前
7秒前
8秒前
思源的应助被elysia采纳,获得30
8秒前
8秒前
8秒前
8秒前
oosr发布了新的文献求助10
9秒前
9秒前
pp发布了新的文献求助10
9秒前
IceyCNZ发布了新的文献求助10
9秒前
初(*^▽^*)心的应助被哭泣冬瓜采纳,获得10
10秒前
酷波er的应助被檀兮尔采纳,获得10
10秒前
Czz发布了新的文献求助10
10秒前
11秒前
serena发布了新的文献求助20
11秒前
忧心的曼凝的应助被沧海云帆采纳,获得10
11秒前
QQ完成签到,获得积分10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183792
求助须知:如何正确求助?哪些是违规求助? 9573020
关于积分的说明 21828776
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434116
关于科研通互助平台的介绍 2558301
邀请新用户注册赠送积分活动 2480611